Importantly, skewed reactivity was particularly significant for the CD4+ T cell subset, which may not only reflect intrinsic differences between the CD4+ and CD8+ T cell response to COVID-19 (46) but also be a direct consequence of the slow functional recovery of engrafted T helper cells, a process that may require years to complete (47, 48). The gene discussed is CD8A; the disease is COVID-19.